NEWS
We’ll be at CPHI Milan 2026
Meet our team at the heart of biopharmaceutical innovation.
We will be attending CPHI Milan, on October 6–8, 2026 | Fiera Milano, Milan, Italy.
Andy Sheldon, CEO of the BMC, will present at the Global Pharma Outlook, Tuesday, October 6, 2026 from 2:15 PM to 2:40 PM (CET) — Hall 7, 7H81
Topic: “Canada’s Biomanufacturing Advantage — Turning Innovation into Global Partnerships” (BMC, technology transfer & international partnerships).
His session will explore how the BMC turns innovation into commercial opportunity — through technology transfer, manufacturing readiness, and international partnerships — for companies looking to expand into North America, reduce investment risk, strengthen supply chain resilience, and accelerate the path from development to production.
Learn more: Conference Agenda
Attending CPHI Milan? Let’s connect.